Drug Database · Clinicians

Ampicillin + Sulbactam

Brands (113) Amsul, Silgram, Sulbacin…Show all
Amsul · Silgram · Sulbacin · Ampimar · Ampimax · Amsulvex · Amsumed · Amsutas · Bactalev 1.5 · Bactalev-750 · Bactamed · Bacticare · Bactinext · Baczillin · Dypisul 750 · Geobactam 1.5 · Gravitam · Haitam · Linsul · Lintam · Miasyn · Pillsulbac · Porbact-1.5 · Porbact-750 · Sambactam · Sporasul · Sulbaxen · Sultacillin · Sulvacil · Synthopen · Unacilyn · Unatrene · Actacil · Aepisul 1.5 · Aepisul 750 · Amebactam-1.5 · Amebactam-750 · Amkotam · Ampicare · Ampihil 1.5 · AMPINEX PLUS · Ampinix -1.5 · Ampinix-750 · AMPIRIXX · Ampisaphtam-15000 · Ampisaphtam-750 · Ampistar S · Ampisuden · Ampisulife · Ampisulmax · Ampitam · Ampix Plus · Amsudime -1.5 · Amsudime-750 · Amsulsyn · Amtacil · Amtacil-WFI · Ansulmax · Ansulmed · Asulbac · Bactacare · Bactacin · Bactacin 750 · Bacticon · Bactisul · Bactropen Plus · Ciltamin 1.5 · Ciltamin 750 · Clestram · Duobaclin · Dypisul 1.5 · Effebactam · Firbactam-1.5 · Gensyn · Geobactam · I-Bactam-1.5 · Incillin Plus 1500 · Liferzin Plus · Novac · Phamsul · Primucitam · RAVITAM · Retaback-750 · Retabacx-1500 · Retasul · Riampisul · RONPIBAC · Sacriva-750 · Sitampex · Sulbacin 0.75 · Sulbacin 1.5 · Sulbaclin · Sulbactizin · Sulbactomax · Sulpi-1500 · Sulpi-750 · Sulpisave-750 · Surpitam-1.5 · Surpitam-750 · Sybactam · UNAMAX · Unamax-750 · Unasyn · Unathix · Unazeus 1.5 · Unazeus 750 · Unazil · Unsin · Vactrimed 1.5g · Vactrimed 750 · Vigosul · Yupitam · Zusillin

Antibacterial (penicillin-beta-lactamase inhibitor combination); Antibacterial (penicillin and beta-lactamase inhibitor); and others PH FDA category
Fixed-dose combination.

CrCl <30: same dose, q12–24hRx · Prescription drug163 PH productsPNF-listed Kidney dosing reviewed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 155c7ec0-5862-404f-b1d0-f278f8a8bbda, version date July 10, 2026 (UNASYN · Roerig). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • INDICATIONS AND USAGE UNASYN is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below.
US FDA label
Full indications and usage US FDA label

INDICATIONS AND USAGE UNASYN is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. Skin and Skin Structure Infections caused by beta-lactamase producing strains of Staphylococcus aureus, Escherichia coli, Efficacy for this organism in this organ system was studied in fewer than 10 infections.

Klebsiella spp. (including K. pneumoniae), Proteus mirabilis, Bacteroides fragilis, Enterobacter spp., and Acinetobacter calcoaceticus. NOTE: For information on use in pediatric patients (see PRECAUTIONS–Pediatric Use and CLINICAL STUDIES sections). Intra-Abdominal Infections caused by beta-lactamase producing strains of Escherichia coli, Klebsiella spp.

(including K. pneumoniae), Bacteroides spp. (including B. fragilis), and Enterobacter spp. Gynecological Infections caused by beta-lactamase producing strains of Escherichia coli, and Bacteroides spp. (including B. fragilis). While UNASYN is indicated only for the conditions listed above, infections caused by ampicillin-susceptible organisms are also amenable to treatment with UNASYN due to its ampicillin content.

Therefore, mixed infections caused by ampicillin-susceptible organisms and beta-lactamase producing organisms susceptible to UNASYN should not require the addition of another antibacterial. Appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify the organisms causing infection and to determine their susceptibility to UNASYN.

Therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies when there is reason to believe the infection may involve any of the beta-lactamase producing organisms listed above in the indicated organ systems. Once the results are known, therapy should be adjusted if appropriate.

To reduce the development of drug-resistant bacteria and maintain effectiveness of UNASYN and other antibacterial drugs, UNASYN should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.

In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Contraindications

  • Serious hypersensitivity (anaphylaxis, Stevens-Johnson syndrome) to ampicillin, sulbactam or other beta-lactams
  • Previous cholestatic jaundice or hepatic dysfunction with ampicillin-sulbactam
renalcarematters.com, reviewed
Contraindications (US label) US FDA label

CONTRAINDICATIONS The use of UNASYN is contraindicated in individuals with a history of serious hypersensitivity reactions (e.g., anaphylaxis or Stevens-Johnson syndrome) to ampicillin, sulbactam or to other beta-lactam antibacterial drugs (e.g., penicillins and cephalosporins). UNASYN is contraindicated in patients with a previous history of cholestatic jaundice/hepatic dysfunction associated with UNASYN.

Dosing: Adult

  • Adults: 1.5 g (ampicillin 1 g + sulbactam 0.5 g) to 3 g (2 g + 1 g) IV or IM every 6 hours
  • Maximum: Sulbactam 4 g/day
  • CrCl below 30 mL/min/1.73 m2: 15–29: every 12 hours; 5–14: every 24 hours
renalcarematters.com, reviewed
Dosage and administration (US label) US FDA label

DOSAGE AND ADMINISTRATION UNASYN may be administered by either the IV or the IM routes. For IV administration, the dose can be given by slow intravenous injection over at least 10–15 minutes or can also be delivered in greater dilutions with 50 mL–100 mL of a compatible diluent as an intravenous infusion over 15–30 minutes.

(see DIRECTIONS FOR USE-Preparation for Intravenous Use section). UNASYN may be administered by deep intramuscular injection (see DIRECTIONS FOR USE-Preparation for Intramuscular Injection section). The recommended adult dosage of UNASYN is 1.5 g (ampicillin 1 g and sulbactam 0.5 g) to 3 g (ampicillin 2 g and sulbactam 1 g) every six hours.

This 1.5 g to 3 g range represents the total of ampicillin content plus the sulbactam content of UNASYN, and corresponds to a range of 1 g ampicillin and 0.5 g sulbactam to 2 g ampicillin and 1 g sulbactam. The total dose of sulbactam should not exceed 4 g per day. Pediatric Patients 1 Year of Age or Older The recommended daily dose of UNASYN in pediatric patients is 300 mg per kg of body weight administered via intravenous infusion in equally divided doses every 6 hours.

This 300 mg/kg/day dosage represents the total ampicillin content plus the sulbactam content of UNASYN, and corresponds to 200 mg ampicillin and 100 mg sulbactam per kg per day. The safety and efficacy of UNASYN administered via intramuscular injection in pediatric patients have not been established. Pediatric patients weighing 40 kg or more should be dosed according to adult recommendations, and the total dose of sulbactam should not exceed 4 g per day.

The course of intravenous therapy should not routinely exceed 14 days. In clinical trials, most pediatric patients received a course of oral antimicrobials following initial treatment with intravenous UNASYN (see CLINICAL STUDIES section). Impaired Renal Function In patients with impairment of renal function the elimination kinetics of ampicillin and sulbactam are similarly affected, hence the ratio of one to the other will remain constant whatever the renal function.

The dose of UNASYN in such patients should be administered less frequently in accordance with the usual practice for ampicillin and according to the following recommendations: TABLE 3 UNASYN Dosage Guide for Patients with Renal Impairment Creatinine Clearance (mL/min/1.73 m²) Ampicillin and Sulbactam Half-Life (Hours) Recommended UNASYN Dosage ≥30 1 1.5 g to 3 g every 6 to 8 hours 15–29 5 1.5 g to 3 g every 12 hours 5–14 9 1.5 g to 3 g every 24 hours When only serum creatinine is available, the following formula (based on sex, weight, and age of the patient) may be used to convert this value into creatinine clearance. The serum creatinine should represent a steady state of renal function.

Males Weight (kg) x (140 – age) 72 x serum creatinine Females 0.85 x above value

Dosing: Altered kidney function

Ampicillin and sulbactam are both about 75% to 85% excreted unchanged in urine, and kidney impairment slows both equally, so their ratio stays constant. The US label gives 1.5 to 3 g at longer intervals as creatinine clearance (CrCl) falls: every 6 to 8 hours at 30 or more, every 12 hours at 15–29 and every 24 hours at 5–14 mL/min/1.73 m2. The label gives no dialysis dose.

Kidney function measure: Label uses CrCl in mL/min/1.73 m2 (Cockcroft–Gault formula quoted); bands at 30 and 15. The mL/min/1.73 m2 unit is the label's own convention and is kept verbatim.

Show full dosing details
CrCl ≥60 mL/min/1.73 m2
1.5 to 3 g every 6 hours (usual); the label's CrCl 30 or more row allows every 6 to 8 hours (label Table 3).
CrCl 30–59 mL/min/1.73 m2
CrCl 30 or more: 1.5 to 3 g every 6 to 8 hours (label Table 3).
CrCl 15–29 mL/min/1.73 m2
CrCl 15–29: 1.5 to 3 g every 12 hours (label Table 3).
CrCl <15 mL/min/1.73 m2 (not on dialysis)
CrCl 5–14: 1.5 to 3 g every 24 hours (label Table 3). Below 5: not stated; specialist input.
Hemodialysis (intermittent)
No hemodialysis dosing in label. Ampicillin is removed by hemodialysis, and sulbactam probably is (label overdose section). Specialist input.
Peritoneal dialysis
No peritoneal dialysis dosing in label. For PD-associated peritonitis (ISPD 2022): continuous intraperitoneal loading dose 1,000 mg/500 mg, then maintenance 133.3 mg/66.7 mg (ampicillin/sulbactam, as printed in ISPD Table 5); no intermittent dose listed. Specialist input.
CRRT
Not in label. Li 2020 (Table 3), sulbactam component: CVVH ultrafiltration 30 mL/kg/h, CVVHD dialysate 1 L/h, or CVVHDF combined 1 L/h, 1 g every 8 hours (1 g sulbactam = ampicillin-sulbactam 3 g); higher doses may be needed for less susceptible organisms, and Li suggests drug level monitoring.
  • Dialyzable? Ampicillin: yes, removed by hemodialysis. Sulbactam: probably, from its size, protein binding and kinetics (label). Protein binding: ampicillin 28%, sulbactam 38%.
  • Monitoring CrCl for dose; seizures with high CSF beta-lactam levels (label overdose section); liver tests (history of cholestatic jaundice is a contraindication); rash; diarrhea (CDAD).
Children (kidney dosing)
Show full dosing details
eGFR ≥60
Usual pediatric dose (label).
eGFR 30–59
No pediatric kidney dosing in label. Specialist input.
eGFR 15–29
No pediatric kidney dosing in label. Specialist input.
eGFR <15 (not on dialysis)
No pediatric kidney dosing in label. Specialist input.
Hemodialysis (intermittent)
No pediatric kidney dosing in label. Specialist input.
Peritoneal dialysis
No pediatric kidney dosing in label. Specialist input.
CRRT
No pediatric kidney dosing in label. Specialist input.

Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.

renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.

US label text: Renal impairment US FDA label

Impaired Renal Function In patients with impairment of renal function the elimination kinetics of ampicillin and sulbactam are similarly affected, hence the ratio of one to the other will remain constant whatever the renal function. The dose of UNASYN in such patients should be administered less frequently in accordance with the usual practice for ampicillin and according to the following recommendations: TABLE 3 UNASYN Dosage Guide for Patients with Renal Impairment Creatinine Clearance (mL/min/1.73 m²) Ampicillin and Sulbactam Half-Life (Hours) Recommended UNASYN Dosage ≥30 1 1.5 g to 3 g every 6 to 8 hours 15–29 5 1.5 g to 3 g every 12 hours 5–14 9 1.5 g to 3 g every 24 hours When only serum creatinine is available, the following formula (based on sex, weight, and age of the patient) may be used to convert this value into creatinine clearance.

The serum creatinine should represent a steady state of renal function. Males Weight (kg) x (140 – age) 72 x serum creatinine Females 0.85 x above value

Dosing: Pediatric

Approved ages
1 year and older (skin and skin structure infections, IV) (label).
Usual dose
300 mg/kg/day IV (200 mg ampicillin plus 100 mg sulbactam per kg), divided every 6 hours; 40 kg or more: adult dose (label).
Maximum dose
Sulbactam 4 g/day; IV course usually not over 14 days (label).

Kidney dosing in children: see Dosing: Altered kidney function.

renalcarematters.com, reviewed
Pediatric use (US label) US FDA label

Pediatric Use The safety and effectiveness of UNASYN have been established for pediatric patients one year of age and older for skin and skin structure infections as approved in adults. Use of UNASYN in pediatric patients is supported by evidence from adequate and well-controlled studies in adults with additional data from pediatric pharmacokinetic studies, a controlled clinical trial conducted in pediatric patients and post-marketing adverse events surveillance (see CLINICAL PHARMACOLOGY, INDICATIONS AND USAGE, ADVERSE REACTIONS, DOSAGE AND ADMINISTRATION, and CLINICAL STUDIES sections).

The safety and effectiveness of UNASYN have not been established for pediatric patients for intra-abdominal infections.

Dosage forms

Philippines

  • Powder for injection: 0 mg/250 mg, 1 g/500 mg, 1.5 g, 250 mg/125 mg, 500 mg/250 mg, 750 mg
  • Powder for solution for injection: 1 g/500 mg, 500 mg/250 mg
  • ) powder for injection: 500 mg/250 mg (750 mg
  • Per vial powder for injection: 1 g/500 mg
  • Powder for solution for i.m/i.v: 500 mg/250 mg
  • Sterile powder for injection: 750 mg

Registered products in the Philippines

163 products registered with the Food and Drug Administration (FDA) Philippines list Ampicillin + Sulbactam as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products163
Philippine FDA-registered products for Ampicillin + Sulbactam
Package insert
ActacilAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Glass Vial (Box of 1’s)
Rx
Samjin Pharmaceutical Co., Ltd.Republic Of Korea
UniGlobal Group Marketing Corp.Importer: Medbridge, Inc.
DRP-3252-01
Mar 3, 2031
Aepisul 1.5Ampicillin (As Sodium) + Sulbactam (As Sodium)
1g/500mg Powder For Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
Sahar International Trading, Inc.
DRP-3351-02
Oct 25, 2027
Aepisul 750Ampicillin (As Sodium) + Sulbactam (As Sodium)
500 mg/250 mg Powder For Injection (IM/IV)USP Type I Clear Glass Vial x l's (Box of 1's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
Dynasty PharmaceuticalsImporter: Sahar International Trading, Inc.
DRP-3944-01
Aug 31, 2027
Amebactam-1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)20 mL USP Type III clear and colorless glass vial with gray bromobutyl rubber stopper and aluminum seal with white flip-off cap + 10mL Sterile Water for Injection diluent in LDPE ampoule (Box of 1's)
Rx
Med Biopharma Pvt. Ltd.India
Amedesons Drug HouseImporter: Pors Pharma Trading
DRP-15054-03
Aug 4, 2028
Amebactam-750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial with gray bromobutyl rubber stopper and aluminum seal with white flip-off cap + 10 mL Sterile Water for Injection diluent in LDPE ampoule (Box of 1's)
Rx
Med Biopharm Pvt. Ltd.India
Amedesons Drug HouseImporter: Pors Pharma Trading
DRP-14996-01
Aug 4, 2028
AmkotamAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IV/IM)5 mL USP Type I Clear Glass Vial per box
Rx
Swiss Parenterals LtdIndia
AMK Pharma International TradingImporter: Ambica International Corporation
DRP-6930-07
Sep 30, 2027
AmpicareAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (I.M./I.V.)USP Type I Borosilicate Clear Transparent Glass Vial with Butyl Rubber Stopper Sealed with Aluminum Plastic Cap and Blue Flip-Off x 7 mL Box of 1’s in 10’s; USP Type I Borosilicate Clear Transparent Glass Vial with Butyl Rubber Stopper Sealed with Aluminum Plastic Cap and Blue Flip-Off x 7 mL Box of 10's
Rx
NORTH CHINA PHARMACEUTICAL CO., LTD.China
AGLOBAL CARE, INC.
DRP-8057
Jul 10, 2028
Ampihil 1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/ 500 mg Powder for Injection (I.M./I.V.)10 mL clear Type I tubular glass vial with butyl rubber stopper and flip-off cap (Box of 1's and Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc.
DRP-10602-01
Oct 22, 2031
AmpimarAmpicillin (As Sodium) + Sulbactam (As Sodium)
1g/500mg Powder For Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
Amson PharmaceuticalsImporter: Sahar International Trading, Inc.
DRP-3351-01
Oct 25, 2027
AmpimarAmpicillin (As Sodium) + Sulbactam (As Sodium)
500mg/250mg Powder For Injection (IM/IV)USP Type I Clear Glass Vial x l's (Box of 1's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
Amson PharmaceuticalsImporter: Sahar International Trading, Inc.
DRP-3944-02
Aug 31, 2027
AmpimaxAmpicillin (as sodium) + Sulbactam (as sodium)
1.5 g Powder for Injection (I.M./I.V.)20 mL USP Type I Glass Vial with Grey Butyl Rubber Closure with Leaf Green Aluminum Flip-off seal Box of 1’s
Rx
Unichem Laboratories Limited (Unit I)India
UNILAB, Inc.Importer: Ambica International Corporation
DRP-3649-01
Dec 18, 2028
AmpimaxAmpicillin (as sodium) + Sulbactam (as sodium)
750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Glass Vial with Grey Butyl Rubber Closure with Burgundy Aluminum Flip-off seal Box of 1’s
Rx
Unichem Laboratories Ltd (Unit I)India
UNILAB, Inc.Importer: Ambica International Corporation
DRP-3648-01
Dec 18, 2028
AMPINEX PLUSAmpicillin (as Sodium) + Sulbactam (as Sodium)
1g/500 mg Powder for Injection (I.M./1.V.)USP Type I Tubular Clear Glass Vial with blue Plastic flip-off x 10 mL Box of 1's
Rx
Reyoung Pharmaceutical Co., Ltd.China
NEXT CHEMICAL ENTERPRISES
DRP-9340
Dec 27, 2028
Ampinix -1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1’s)
Rx
Yeluri Formulations Pvt. Ltd.India
Ranixx PharmaceuticalsImporter: Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5009-05
Dec 11, 2028
Ampinix-750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial Box of 1’s
Rx
Yeluri Formulations Pvt. Ltd.India
Ranixx PharmaceuticalsImporter: Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5007-04
Dec 11, 2028
AMPIRIXXAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)12 mL USP Type II Colorless Glass Vial Individually Packed in a box (Box of 10's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Development Zone, Shijiazhuang, ChinaChina
BIO ERIXX PHARMA DISTRIBUTIONImporter: AMB HK Enterprises Inc.
DRP-5102-06
Feb 6, 2032
Ampisaphtam-15000Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg powder for Injection (IM/IV)10 mL-capacity USP Type I clear glass vial with grey bromo butyl rubber stopper and royal blue coloured flip off seal (Box of 1's and 10's)
Rx
Bueno Salud Care (India) Pvt. Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt., Ltd.
DRP-15371
Jun 28, 2029
Ampisaphtam-750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I clear glass vial with grey bromo butyl rubber stopper and royal blue coloured aluminum flip- off seal (Box of 1's and 10's)
Rx
Bueno Salud Care (India) Pvt. Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt., Ltd.
DRP-15373
Jun 28, 2029
Ampistar SAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (I.V./I.M.)USP Type III clear glass vial closed with bromo butyl rubber stopper and sealed with blue flip off seal (Box of 10's)
Rx
Inject Care Parenterals Pvt. Ltd.India
Pharmastar Int'l Trading Corp.
DRP-14646
Nov 14, 2028
AmpisudenAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)12 mL USP Type II Colorless Glass Vial Individually packed in a box (Box of 10’s)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
Cyden Medicale Trading, Inc.Importer: AMB HK Enterprises, Inc.
DRP-5102-05
Feb 8, 2031
AmpisulifeAmpicillin (As Sodium) + Sulbactam (As Sodium)
1 g/500 mg Powder for Injection (I.M./I.V.)USP Type I clear glass vial x 10 mL (net content) with grey bromobutyl rubber stopper, aluminum seal and flip-off cap (Box of 1’s + 5 mL clear glass ampoule diluent; Box of 10’s)
Rx
Anhil Parenteral Pvt. Ltd.India
Biophil Medical Equipment and Supplies Trading
DRP-18549
Jul 29, 2031
AmpisulmaxAmpicillin (as sodium) + Sulbactam (as sodium)
1g / 500mg Powder for Injection (I.V. / I.M.)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Blue Flip-off Cap and Sterile Water for Injection as Diluent in USP Type I Clear and Colorless Glass Ampoule x 10mL (Box of 1 Vial + 1 Ampoule)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Dreamax Life Sciences IncorporatedImporter: Dreamax Incorporated
DRP-11209-02
Feb 15, 2027
AmpitamAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)12 mL USP Type II Colorless Glass Vial individually packed in a box (Box of 10's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
Twostar Pharmaceutical TradingImporter: AMB HK Enterprises Inc.
DRP-5102
Feb 8, 2031
Ampix PlusAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Glass Vial (Box of 1’s)
Rx
Samjin Pharmaceutical Co., Ltd.Republic Of Korea
Nutramedica Inc.Importer: Medbridge, Inc.
DRP-3252-02
Mar 3, 2031
Amsudime -1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1’s)
Rx
Yeluri Formulations Pvt. Ltd.India
Pharmadyme Philippines, Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5009-03
Dec 11, 2028
Amsudime-750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1’s)
Rx
Yeluri Formulations Pvt. Ltd.India
Pharmadyme Philippines, Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5007-03
Dec 11, 2028
AmsulAmpicillin (as Sodium) + Sulbactam (as Sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1's)
Rx
Swiss Parenterals Ltd.India
Endure Medical, Inc.
DR-XY46329
May 4, 2028
AmsulAmpicillin (as Sodium) + Sulbactam (as Sodium)
1g / 500 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1's)
Rx
Swiss Parenterals Ltd.India
Endure Medical, Inc.
DRP-15941
May 4, 2028
AmsulAmpicillin (as Sodium) + Sulbactam (as Sodium)
1g/500mg Powder for Injection (IM/IV)Clear Glass Vial with Rubber Stopper and Blue flip-off seal placed in plastic tray (Box of 10's)
Rx
Singapore Pharmawealth Lifesciences, Inc.Laguna
Endure Medical, Inc.Trader: Phil. Pharmawealth, Inc.
DRP-1556-03
Nov 19, 2027
AmsulAmpicillin (as Sodium) + Sulbactam (as Sodium)
500 mg / 250 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1's)
Rx
Swiss Parenterals Ltd.India
Endure Medical, Inc.
DRP-15940
May 4, 2028
AmsulAmpicillin (as Sodium) + Sulbactam (as Sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1's)
Rx
Swiss Parenterals Ltd.India
Endure Medical, Inc.
DR-XY46330
May 4, 2028
AmsulAmpicillin (as Sodium) + Sulbactam (as Sodium)
500mg / 250mg Powder for Injection (I.V./I.M.)Clear glass vial with rubber stopper and yellow flip-off seal placed in plastic tray (Box of 10's)
Rx
Singapore Pharmawealth Lifesciences, Inc.Laguna
Endure Medical, Inc.Trader: Phil. Pharmawealth, Inc.
DRP-2337-03
Dec 14, 2029
AmsulsynAmpicillin (As Sodium) + Sulbactam (As Sodium)
500 mg/ 250 mg Powder For Injection (IV/IM)5 mL USP Type 1 Clear Glass Vial per box
Rx
Swiss Parenterals Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-6930-12
Apr 27, 2031
AmsulvexAmpicillin (as Sodium) + Sulbactam (as Sodium)
1 g/500 mg Powder for Injection (IM/IV)Type III Clear Glass Vial with Blue Flip-off Seal (Box of 1's and 10's)
Rx
NORTH CHINA PHARMACEUTICAL CO., LTDChina
SANNOVEX PHARMACEUTICAL DISTRIBUTOR
DRP-2578
May 14, 2029
AmsulvexAmpicillin (as Sodium) + Sulbactam (as Sodium)
500 mg/250 mg Powder for Injection (IM/IV)Type III Clear Glass Vial with blue flip-off seal (Box of 1's and 10's)
Rx
NORTH CHINA PHARMACEUTICAL CO., LTDChina
SANNOVEX PHARMACEUTICAL DISTRIBUTOR
DRP-2575
May 14, 2029
AmsumedAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/ 500 mg Powder for Injection (I.M./I.V.)10 mL clear Type I tubular glass vial with butyl rubber stopper and flip-off cap (Box of 1's) and (Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Sanimed Pharmaceuticals Inc.
DRP-10602
Oct 22, 2036
AmsumedAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg /250 mg Powder for Injection (I.M./I.V.)10 mL clear Type I tubular glass vial with butyl rubber stopper and flip-off cap (Box of 1's) and (Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Sanimed Pharmaceuticals Inc.
DRP-10603
Oct 22, 2036
AmsutasAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1’s)
Rx
Yeluri Formulations Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5009
Dec 11, 2028
AmsutasAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1’s)
Rx
Yeluri Formulations Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5007
Dec 11, 2028
AmtacilAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)10 mL-capacity USP Type II glass vial with butyl rubber stopper and flip-off cap (Box of 10's)
Rx
Reyoung Pharmaceutical Co., LtdChina
Dreamax Incorporated
DRP-15749
Sep 10, 2029
Amtacil-WFIAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (I.V./I.M.)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Blue Flip-off Cap and Sterile Water for Injection as Diluent in USP Type I Clear
Rx
Reyoung Pharmaceutical Co., Ltd.China
Dreamax Incorporated
DRP-11209
Feb 15, 2027
AnsulmaxAmpicillin (as sodium) + Sulbactam (as sodium)
1g/500mg Powder for Injection (IV/IM)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Blue Flip-off Cap and Sterile Water for Injection as Diluent in USP Type I Clear and Colorless Glass Ampoule x 10 mL (Box of 1 Vial + 1 Ampoule)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Dreamax Life Sciences IncorporatedImporter: Dreamax Incorporated
DRP-11209-03
Feb 15, 2027
AnsulmedAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/ 500 mg Powder for Injection (I.V./I.M.)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Blue Flip-off Cap and Sterile Water for Injection as Diluent in USP Type I Clear and Colorless Glass Ampoule x 10mL (Box 1 Vial + 1 Ampoule)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Dreamax Life Sciences IncorporatedImporter: Dreamax Incorporated
DRP-11209-01
Feb 15, 2027
AsulbacAmpicillin (as sodium) + Sulbactam (as sodium)
1g/ 500mg Powder for Injection (I.V./I.M.)20 mL-capacity USP Type III clear and colorless glass vial with grey butyl rubber stopper and aluminum seal with cream colored flip-off cap + 5 mL (net content) LDPE ampoule of Sterile Water for Injection as diluent in opaque white plastic tray (Box of 1's)
Rx
Akums Drugs & Pharmaceuticals Ltd.India
Hexagon Pharmaceuticals
DR-XY47597
Dec 9, 2026
BactacareAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)12 mL USP Type II Colorless Glass Vial Individually Packed in a box (Box of 10's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
Msf Pharmaceutical ProductsImporter: AMB HK Enterprises Inc.
DRP-5102-03
Feb 4, 2032
BactacinAmpicillin(as sodium)+Sulbactam(as sodium)
1g/500mg Powder for Injection(IM/IV)USP Type I Glass Vial x 10's Box of 10's
Rx
Shin Poong Pharmaceutical Co., Ltd.Korea
Phil Shinpoong Pharma, Inc.
DRP-5382
Jul 10, 2029
Bactacin 750Ampicillin (as Sodium) + Sulbactam (as Sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Glass Vial x 10's (Box of 10's)
Rx
Shin Poong Pharmaceutical Co., Ltd.Korea
Phil. Shin Poong Pharma, Inc.
DRP-5442
May 31, 2027
Bactalev 1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g / 500 mg Powder for Solution for Injection (I.M./I.V.)20 mL USP Type III clear glass vial closed with 20 mm grey bromo butyl rubber stopper and blue aluminum flip off - seal (Box of 1's and 10's)
Rx
Inject Care Parenterals Pvt. Ltd.India
HLM Pharmaceutical Inc.Importer: Orange Biotec Inc.
DRP-11727-01
Apr 22, 2027
Bactalev 1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1’s)
Rx
Yeluri Formulations Pvt. Ltd.India
HLM Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5009-06
Dec 11, 2028
Bactalev 750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg / 250 mg Powder for Solution for Injection (I.M./I.V.)USP Type III Clear Glass Vial with Grey Butyl Rubber Stopper and Aluminum Flip-off Seal (Box of 1's and 10's)
Rx
Inject Care Parenterals Pvt. Ltd.India
HLM Pharmaceutical Inc.Importer: Orange Biotec Inc.
DRP-12470-01
Aug 16, 2027
Bactalev-750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1’s)
Rx
Yeluri Formulations Pvt. Ltd.India
HLM Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5007-05
Dec 11, 2028
BactamedAmpicillin (as sodium) + Sulbactam (as sodium)
1 g / 500 mg Powder for Injection (I.M./I.V.)10 mL Type II tubular glass vial with butyl rubber stopper with a flip off cap (Box of 1’s)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Medirich Pharma Distribution Corp.Importer: Aglobal Care, Inc.
DRP-11962-03
May 24, 2027
BactamedAmpicillin (As Sodium) + Sulbactam (As Sodium)
500mg/250mg Powder For Injection (IV/IM)USP Type II glass vial x 10 mL sealed with butyl rubber stopper and aluminum flip-off cap (Box of 1’s)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Medirich Pharma Distribution Corp.Importer: Aglobal Care, Inc.
DRP-12252-04
Jul 4, 2027
BacticareAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (I.M./I.V.)Molded glass vial with butyl rubber stopper and aluminum-plastic cap (Box of 1’s)
Rx
North China Pharmaceutical Co., Ltd.China
Euro-Care Products Philippines
DRP-12026
May 31, 2027
BacticareAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg /250 mg Powder for Injection (I.M./I.V.)Molded glass vial with halogenated butyl rubber stopper and aluminum-plastic caps (Box of 1’s)
Rx
North China Pharmaceutical Co., Ltd.China
Euro-Care Products Philippines
DRP-12025
May 31, 2027
BacticonAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/ 500 mg Powder for Injection (I.M./I.V.)10 mL clear Type I tubular glass vial with butyl rubber stopper and flip-off cap (Box of 1's and 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.Shandong Province China
D'Conner PharmaImporter: Sanimed Pharmaceuticals Inc.
DRP-10602-02
Oct 22, 2031
BactinextAmpicillin (as sodium) + Sulbactam (as sodium)
1g / 500 mg Powder for Injection (I.V./I.M)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Flip-off Cap (Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Diafarm Inc.Importer: Ambicare Pharmaceuticals Inc.
DRP-11465-01
Mar 15, 2027
BactinextAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg / 250 mg Powder for Injection (I.V./I.M)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Flip-off Cap (Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Diafarm Inc.Importer: Ambicare Pharmaceuticals Inc.
DRP-11464-01
Mar 15, 2027
BactisulAmpicillin (as sodium) + Sulbactam (as sodium)
1g / 500mg Powder for Injection (I.M/I.V.)20 mL USP Type II moulded glass vial with butyl rubber stopper and flip-off cap + 10 mL ampoule (Sterile Water for Injection as diluent) [Box of 1's]
Rx
Reyoung Pharmaceutical Co., Ltd.China
Reta DrugImporter: Medinova Pharmaceutical Inc.
DRP-11662-02
Apr 7, 2027
Bactropen PlusAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/ 500 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial (Box of 1’s)
Rx
Samjin Pharmaceutical Co., Ltd.Republic Of Korea
Medhaus Pharma, IncorporatedImporter: Medbridge, Inc.
DRP-5298-01
Mar 3, 2031
BaczillinAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)10 mL-capacity glass vial with butyl rubber stopper and aluminum flip-off seal (Box of 1's and 10's)
Rx
North China Pharmaceutical Co., Ltd.China
GPC Geo Pharma Corporation.Trader: Kwan Star Co., Ltd.
DRP-15490
Jul 30, 2029
BaczillinAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)10 mL-capacity glass vial with butyl rubber stopper and aluminum flip-off seal (Box of 1's and 10's)
Rx
North China Pharmaceutical Co., Ltd.China
GPC Geo Pharma CorporationTrader: Kwan Star Co., Ltd.
DRP-15491
Jul 30, 2029
Ciltamin 1.5Ampicillin (as Sodium) + Sulbactam (as Sodium)
1 g/ 500 mg Powder for Injection (I.M./I.V.)USP Type I glass vial with orange coloured flip-off seal (Box of 1’s)
Rx
SAMJIN PHARMACEUTICAL CO., LTD.Republic of Korea
NATRAPHARM, INC.
DR-XY39040
Feb 10, 2029
Ciltamin 750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/ 250 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial with Green Coloured Flip-off Seal (Box of 1’s)
Rx
SAMJIN PHARMACEUTICAL CO., LTD.Republic of Korea
NATRAPHARM, INC.
DR-XY38898
Dec 28, 2028
ClestramAmpicillin (as Sodium) + Sulbactam (as Sodium)
500 mg/250 mg Powder for Injection (I.M./I.V.)USP Type III Glass Vial with rubber stopper and white flip-off seal (Box of 1 vial + 1 diluent)
Rx
ZAZEN PHARMA PVT. LTD.India
Medethix, Inc.Importer: I.E. Medica, Inc.Trader: Stratgen Healthcare Pvt. Ltd.
DRP-2607-03
Nov 22, 2028
DuobaclinAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IV/IM)5 mL USP Type I Clear Glass Vial per box
Rx
Swiss Parenterals Ltd.India
Euparex Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-6930-08
Sep 29, 2030
Dypisul 1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1G/500mg Powder for Injection (I.M./I.V.)10 mL-capacity USP Type II clear and colorless glass vial enclosed with butyl rubber stopper and aluminum seal with blue flip-off cap (Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Dynasty Pharmaceuticals
DR-XY48827
Jul 28, 2028
Dypisul 750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg / 250 mg Powder for Injection (IM/IV)10 mL- capacity USP Type II clear and colorless glass vial enclosed with butyl rubber stopper and aluminum seal with blue flip-off cap (Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Dynasty Pharmaceuticals
DRP-15161
Jul 28, 2028
Dypisul 750Ampicillin (as sodium) + Sulbactam (as sodium)
500mg/250mg Powder For Injection (IM/IV)10 mL-capacity USP Type II clear and colorless glass vial enclosed with butyl rubber stopper and aluminum seal with blue flip-off cap (Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Dynasty Pharmaceuticals
DR-XY48826
Jul 28, 2028
EffebactamAmpicillin (as sodium) + Sulbactam ( as sodium)
500mg/250mg Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial (Box of 1's) (Box of 1's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
Sahar Pharmaceuticals DistributionImporter: Sahar International Trading, Inc.
DRP-3944-03
Dec 10, 2030
Firbactam-1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1g/ 500mg Powder for Injection (IM/IV)20 mL USP Type III clear and colorless glass vial with gray bromobutyl rubber stopper and aluminum seal with white flip-off cap + 10 mL Sterile Water for Injection diluent in LDPE ampoule (Box of 1's)
Rx
Med Biopharm Pvt. Ltd.India
Medarruz Pharmaceutical Philippines IncImporter: Pors Pharma Trading
DRP-15054-01
Aug 4, 2028
GensynAmpicillin (Sodium) + Sulbactam (Sodium)
1 g/500 mg Powder for Injection (I.M./I.V)20 mL USP Type II Moulded Glass Vial with Butyl Rubber Stopper and Flip-off Cap + 10 mL Ampoule (Sterile Water for Injection as Diluent) [Box of 1's]
Rx
Reyoung Pharmaceutical Co. Ltd.China
GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc.
DRP-11662-01
Apr 27, 2027
GeobactamAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1’s)
Rx
Yeluri Formulations Pvt. Ltd.India
GPC Geo Pharma CorporationImporter: Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5007-02
Dec 11, 2028
Geobactam -1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1’s)
Rx
Yeluri Formulations Pvt. Ltd.India
GPC Geo Pharma CorporationImporter: Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5009-02
Dec 11, 2028
Geobactam 1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Solution for Injection (I.M./I.V.)20 mL USP Type III clear glass vial closed with 20 mm grey bromo butyl rubber stopper and blue aluminum flip-off seal (Box of 1's)
Rx
Inject Care Parenterals Pvt. Ltd.India
GPC Geo Pharma CorporationImporter: Orange Biotec Inc.
DRP-11727-02
Apr 22, 2027
GravitamAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type 1 Clear Glass Vial (Box of 1’s)
Rx
Yeluri Formulations Pvt. Ltd.India
Ellebasy Medicale TradingImporter: Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5009-01
Dec 11, 2028
GravitamAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1’s)
Rx
Yeluri Formulations Pvt. Ltd.India
Ellebasy Medicale TradingImporter: Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd.
DRP-5007-01
Dec 11, 2028
HAITAMAmpicillin (as Sodium) + Sulbactam (as Sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I Tubular Clear Glass Vial with Blue Plastic Flip-off x 10 mL (Box of 1's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
GREENCORE PHARMA INC.Importer: NEXT CHEMICAL ENTERPRISES
DRP-9340-02
Dec 27, 2028
HaitamAmpicillin (as Sodium) + Sulbactam (as Sodium)
500mg/250 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Colorless Glass Vial with Butyl Rubber Stopper and Aluminum Crimp with Blue Plastic Flip-Off Cap (Box of 1's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Dynasty PharmaceuticalsImporter: Next Chemical Enterprises
DRP-9341-03
Mar 11, 2029
I-Bactam-1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1g/500 mg Powder for Injection (IM/IV)20 mL USP Type III clear and colorless glass vial with gray bromobutyl rubber stopper and aluminum seal with white flip-off cap + 10 mL Sterile Water for Injection diluent in LDPE ampoule (Box of 1's)
Rx
Med Biopharm Pvt. Ltd.India
Fier Pharma Trading Inc.Importer: Pors Pharma Trading
DRP-15054-02
Aug 4, 2028
Incillin Plus 1500Ampicillin (As Sodium) + Sulbactam (As Sodium)
1 g/ 500 mg Powder For Injection (I.M./I.V.)20 mL-capacity USP Type III clear glass vial with. bromobutyl rubber stopper and aluminum seal with blue flip-off cap (Box of 1's)
Rx
Injectcare Parenterals Pvt LtdIndia
Aglobal Care, Inc.Trader: Antila Lifesciences Pvt. Ltd.
DRP-14761
Dec 22, 2028
Liferzin PlusAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg (750 mg) Powder For Injection (IM/IV)Type II Clear glass vial x 10 mL (Box of 1's and 10's)
Rx
Reyoung Pharmaceuticals Co., Ltd.China
Philgen Pharmaceuticals Inc.
DRP-18365
Jun 22, 2031
LinsulAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/ 500 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial (Box of 1’s)
Rx
Samjin Pharmaceutical Co., Ltd.Republic of Korea
Medbridge, Inc.
DRP-5298
Mar 3, 2031
LinsulAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/ 250 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial (Box of 1’s)
Rx
Samjin Pharmaceutical Co., Ltd.Republic of Korea
Medbridge, Inc.
DRP-3252
Mar 3, 2031
LintamAmpicillin (As Sodium) + Sulbactam(As Sodium)
1 g/500 mg Powder For Solution For Injection (I.M/I.V.)20 mL USP Type III clear glass vial closed with 20 mm grey bromo butyl rubber stopper and blue aluminum flip off-seal (Box of 1's and 10's)
Rx
Inject Care Parenterals Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.
DRP-11727
Apr 22, 2027
LintamAmpicillin (As Sodium) + Sulbactam(As Sodium)
500 mg/ 250 mg Powder for Injection (I.V./I.M.)USP Type III Clear Glass Vial with Grey Butyl Rubber Stopper and Aluminum Flip-off Seal (Box of 10's)
Rx
Inject Care Parenterals Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.
DRP-12470
Aug 16, 2027
MiasynAmpicillin (As Sodium) + Sulbactam (As Sodium)
1g/500mg Powder For Injection (IM/IV)USP Type I Clear Glass Vial (Box of 1's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
Sahar International Trading, Inc.
DRP-3351
Oct 25, 2027
MiasynAmpicillin (As Sodium) + Sulbactam (As Sodium)
500mg/250mg Powder For Injection (IM/IV)USP Type I clear glass vial (Box of 1's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
Sahar International Trading, Inc.
DRP-3944
Aug 31, 2027
NoneAmpicillin (as sodium) + Sulbactam (as sodium)
1 g / 500 mg Powder for Injection (I.V./I.M)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Flip-off Cap (Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Reta DrugImporter: Ambicare Pharmaceuticals Inc.
DRP-11465-03
Mar 15, 2027
NoneAmpicillin (as Sodium) + Sulbactam (as sodium)
1 g /500 mg Powder for Injection (I.M./I.V.)10 mL Type II tubular glass vial with butyl rubber stopper with a flip off cap (Box of 1's)
Rx
Reyoung PharmaceuticalChina
Ritemed Phils., Inc.Importer: Aglobal Care, Inc.
DRP-11962-02
Jul 4, 2027
NoneAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I Glass Vial x 10’s (Box of 10’s)
Rx
Shin Poong Pharmaceutical Co., Ltd.Republic of Korea
Ritemed Phils., Inc.Importer: Phil Shin Poong Pharma, Inc.
DRP-5382-03
Jul 10, 2029
NoneAmpicillin (as sodium) + Sulbactam (as sodium)
1.5 g Powder for Injection (I.M./I.V.)20 mL USP Type I Glass Vial with Grey Butyl Rubber Closure with Leaf Green Aluminum Flip-off seal Box of 1’s
Rx
Unichem Laboratories Limited (Unit I)India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-3649-02
Dec 18, 2028
NoneAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg / 250 mg Powder for Injection (IM/IV)USP Type I Glass Vial x 10’s (Box of 10’s)
Rx
Shin Poong Pharmaceutical Co., Ltd.Republic of Korea
Medicos Bio-Life Sciences, Inc.Importer: Phil. Shin Poong Pharma, Inc.
DRP-5442-04
May 31, 2027
NoneAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/ 250 mg Powder for Injection (I.M./I.V.)USP Type I clear Glass Vial (Box of 1’s)
Rx
Unichem Laboratories Limited (Unit I)India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-5132-01
Feb 13, 2029
NoneAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (I.V./I.M)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Flip-off Cap (Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Reta DrugImporter: Ambicare Pharmaceuticals Inc.
DRP-11464-02
Mar 15, 2027
NoneAmpicillin (as Sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IV/IM)USP Type II glass vial x 10 mL sealed with butyl rubber stopper and aluminum flip-off cap (Box of 1's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Ritemed Phils., Inc.Importer: Aglobal Care, Inc.
DRP-12252-03
Jul 4, 2027
NovacAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (I.M./I.V.)20 mL USP Type II moulded glass vial with butyl rubber stopper and flip-off cap + 10 mL ampoule (Sterile Water for Injection as diluent) [Box of 1's]
Rx
Reyoung Pharmaceutical Co., Ltd.China
Medinova Pharmaceutical Inc.
DRP-11662
Apr 7, 2027
PhamsulAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type III Glass Vial with rubber stopper and white flip-off seal (Box of I vial + 1 diluent)
Rx
Zazen Pharma Pvt. Ltd.India
I.E. Medica, Inc.Trader: Stratgen Healthcare Pvt. Ltd.
DRP-2607
Nov 22, 2028
PillsulbacAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (I.V/I.M)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Flip-off Cap (Box of 10’s)
Rx
Reyoung Pharmaceutical Co., Ltd.China
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambicare Pharmaceuticals Inc.
DRP-11465-04
Mar 15, 2027
PillsulbacAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (I.V./I.M.)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Flip-off Cap (Box of 10’s)
Rx
Reyoung Pharmaceutical Co., Ltd.China
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambicare Pharmaceuticals Inc.
DRP-11464-03
Mar 15, 2032
Porbact-1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g / 500 mg Powder for Injection (IM/IV)20 mL USP Type III clear and colorless glass vial with gray bromobutyl rubber stopper and aluminum seal with white flip-off cap + 10 mL Sterile Water for Injection diluent in LDPE ampoule (Box of 1's)
Rx
Med Biopharm Pvt. Ltd.India
Pors Pharma Trading
DRP15054
Aug 4, 2028
Porbact-1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)FBA 20 mL USP Type III clear and colorless glass vial with gray bromobutyl rubber stopper and aluminum seal with white flip-off cap + 10 mL Sterile Water for Injection diluent in LDPE ampoule (Box of 1's)
Rx
Med Biopharm Pvt. Ltd.India
Pors Pharma Trading
DR-XY48837
Aug 4, 2028
Porbact-750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg / 250 mg Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial with gray bromobutyl rubber stopper and aluminum seal with white flip-off cap + 10 mL Sterile Water for Injection diluent in LDPE ampoule (Box of 1's)
Rx
Med Biopharm Pvt. Ltd.India
Pors Pharma Trading
DRP-14996
Aug 4, 2028
Porbact-750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 Powder for Injection (IM/IV)10 mL USP Type III clear and colorless glass vial with gray bromobutyl rubber stopper and aluminum seal with white flip-off cap + 10 mL Sterile Water for Injection diluent in LDPE ampoule (Box of 1's)
Rx
Med Biopharm Pvt. Ltd.India
Pors Pharma Trading
DR-XY48838
Aug 4, 2028
PrimucitamAmpicillin (as sodium) + Sulbactam (as sodium)
1.5 g Powder for Injection (I.M./I.V.)20 mL USP Type I Glass Vial with Grey Butyl Rubber Closure with Leaf Green Aluminum Flip-off Seal (Box of 1’s)
Rx
Unichem Laboratories Limited (Unit I)India
AGB Pharmaceutical Trading and Consultancy Corp.Importer: Ambica International Corporation
DRP-3649-03
Dec 18, 2028
RAVITAMAmpicillin (as Sodium) + Sulbactam (as Sodium)
1g/500 mg Powder for Injection (I.M./1.V.)USP Type I Tubular Clear Glass Vial with blue Plastic flip-off x 10 mL Box of 1's
Rx
Reyoung Pharmaceutical Co., Ltd.China
TRIPLE TACT IMPORT & EXPORT CORP.Importer: NEXT CHEMICAL ENTERPRISES
DRP-9340-01
Dec 27, 2028
Retaback-750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg / 250 mg Powder for Injection (IV/IM)USP Type II Glass Vial x 10 mL sealed with butyl rubber stopper and aluminum flip-off cap (Box of 1's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Reta DrugImporter: Aglobal Care, Inc.
DRP-12252-01
Jul 4, 2027
Retabacx-1500Ampicillin (as Sodium) + Sulbactam (as Sodium)
1 g/500 mg Powder for Injection (I.M./I.V.)10 mL Type II Tubular glass vial with butyl rubber stopper with a flip off cap (Box of 1's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Reta DrugImporter: Aglobal Care, Inc.
DRP-11962-01
May 24, 2027
RetasulAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
AMB HK Enterprises Inc.
DRP-8955-01
Feb 11, 2031
RiampisulAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/ 250 mg Powder for Injection (I.M./I.V.)USP Type I clear colorless glass vial with grey butyl rubber stopper and aluminum cap with blue flip-off seal x 10 mL (Box of 1's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Champion Biotech and Pharma Corporation
DR-XY34335
Mar 7, 2028
RONPIBACAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)12 mL USP Type II Colorless Glass Vial Individually Packed in a box (Box of 10's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
Medhart Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-5102-01
Feb 4, 2032
Sacriva-750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)12 mL USP Type II Colorless Glass Vial in a box (Box of 10’S)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-5102-04
Dec 13, 2031
SambactamAmpicillin (as Sodium) + Sulbactam (as Sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial with Rubber Plug and Sealed with Aluminum Seal (Box of 10's)
Rx
Singapore Pharmawealth Lifesciences, Inc.Philippines
—
DR-XY45448
Jun 13, 2031
SambactamAmpicillin (as sodium) + Sulbactam (as sodium)
50 0mg/250 mg Powder for Injection (IM/IV)USP Type I clear glass vial sealed with rubber plug and aluminum seal (Box of 10's)
Rx
Singapore Pharmawealth Lifesciences, Inc.Philippines
—
DR-XY46618 (FOR EXPORT ONLY)
Jun 20, 2029
SilgramAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (I.M./I.V.)Type III Clear Glass Vial with Rubber stopper and Aluminum Seal Box of 1's
Rx
YSS Laboratories Co., Inc.Philippines
Trader: The Cathay Drug Co., Inc.
DR-XY36108
Jun 30, 2029
SilgramAmpicillin (As Sodium) + Sulbactam (As Sodium)
250 mg / 125 mg Powder For Injection (IM/IV)1 Clear Glass Vial with secondary box
Rx
YSS Laboratories Co. Inc.Philippines
Trader: The Cathay Drug Company Inc.
DR-XY30362
Nov 25, 2026
SilgramAmpicillin (As Sodium) + Sulbactam (As Sodium)
500 mg / 250 mg Powder For Injection (IM/IV)Type III Clear Glass Vial with Rubber Stopper and Gold Aluminum Seal
Rx
YSS Laboratories Co., Inc.Philippines
Trader: The Cathay Drug Company Inc.
DR-XY30361
Nov 25, 2026
SitampexAmpicillin (as sodium) + Sulbactam (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (I.M./I.V.)USP Type II glass tubular vial with butyl rubber stopper and aluminum-cap (Box of 1's)
Rx
Reyoung Pharmaceutical Co., LTD.China
Sahar International Trading Inc.
DR-XY49230
Sep 25, 2029
SporasulAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (I.M./I.V.)Type I transparent colorless glass vial with bromobutyl elastic rubber stopper of aluminum flip off cap covered with polypropylene plastic cap + Type I colorless glass ampoule x 5 mL (net content as diluent - Sterile Water for Injection) (Box of 1 vial + 1 ampoule)
Rx
Egyptian International Pharmaceutical Industries Co. (EIPICO)Egypt
Ambica International Corporation
DRP-12175
Jun 24, 2032
SporasulAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg / 250 mg Powder For Solution For I.M/I.VPh Eur Type I colorless glass vial + 2 mL water for injection (diluent)
Rx
Egyptian International Pharmaceutical Industries Co. (EIPICO)Egypt
Ambica International Corporation
DRP-12176
Jun 24, 2027
SulbacinAmpicillin (as Sodium) + Sulbactam (as Sodium)
1g/500 mg Powder for Injection (IM/IV)Clear Glass vial with rubber stopper and blue flip-off seal placed in plastic tray (Box of 10's)
Rx
Singapore Pharmawealth Lifesciences, Inc.Philippines
—
DRP-1556
Nov 19, 2027
SulbacinAmpicillin (as Sodium) + Sulbactam (as Sodium)
250 mg / 125 mg Powder for Injection (I.V./I.M.)USP Type I clear glass vial with green flip-off seal (Box of 1's and 10's)
Rx
Singapore Pharmawealth Lifesciences, Inc.Philippines
—
DR-XY30393
Dec 14, 2029
SulbacinAmpicillin (as Sodium) + Sulbactam (as Sodium)
500 mg / 250 mg Powder for Injection (I.V./I.M.)Clear glass vial with rubber stopper and yellow flip-off seal placed in plastic tray (Box of 10's)
Rx
Singapore Pharmawealth Lifesciences, Inc.Philippines
—
DRP-2337
Dec 14, 2029
Sulbacin 0.75Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/ 250 mg Powder for Injection (I.M./I.V.)USP Type I clear Glass Vial (Box of 1’s)
Rx
Unichem Laboratories Limited (Unit I)India
Jalmed Pharma Inc.Importer: Ambica International Corporation
DRP-5132
Feb 13, 2029
Sulbacin 1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/ 500 mg Powder for Injection (I.M./I.V.)USP Type I clear Glass Vial Box of 1’s
Rx
Unichem Laboratories LimitedIndia
Ambica International Corporation
DRP-5079
Feb 11, 2029
SulbaclinAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I Clear Colorless Glass Vial + USP Type I Clear Colorless Glass Ampoule x 10 mL (Diluent) (Box of 1's)
Rx
Kwality Pharmaceuticals LimitedIndia
Clinbaxy International, Inc
DR-XY42178
Jun 28, 2028
SulbactizinAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/ 500 mg Powder for Injection (I.V./I.M.)
Rx
Reyoung Pharmaceutical Co. Ltd.
Basic Pharmaceutical CorporationImporter: Ambicare Pharmaceuticals Inc.
DRP-11465-2
Mar 15, 2027
SulbactomaxAmpicillin (As Sodium) + Sulbactam (As Sodium)
1 g/500 mg Powder for Solution for Injection (IM/IV)USP Type I Clear Glass Vial With Gray Butyl Rubber Stopper and White Aluminum Flip-off Seal (Box of 1's)
Rx
MAAN PHARMACEUTICALS LTDIndia
LABMATE PHARMA INCImporter: STANGEN PHARMACEUTICALS PHILIPPINES INC
DR-XY45073
Feb 22, 2029
SulbaxenAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)20 mL USP Type III colorless glass vial with grey butyl rubber stopper and aluminium seal with red colored flip-off cap (Box of 1's)
Rx
Uni Medicolabs Inc.India
Greencore Pharma Inc.
DRP-15561
Aug 14, 2029
SulbaxenAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)10 mL USP Type III colorless glass vial with grey butyl rubber stopper and aluminium seal with golden colored flip-off cap (Box of 1's)
Rx
Uni Medicolabs Inc.India
Greencore Pharma Inc.
DRP-15562
Aug 14, 2029
Sulpi-1500Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (I.M./I.V.)10 mL Type II tubular glass vial with butyl rubber stopper with a flip off cap (Box of l’s)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Aglobal Care, Inc.
DRP-11962
May 24, 2027
Sulpi-750Ampicillin (As Sodium) + Sulbactam (As Sodium)
500mg/250mg Powder For Injection (IV/IM)USP Type II glass vial x 10 mL sealed with butyl rubber stopper and aluminum flip-off cap (Box of 1’s)
Rx
Reyoung Pharmaceutical Co., Ltd.China
AGlobal Care, Inc.Importer: Aglobal Care, Inc.
DRP-12252
Jul 4, 2027
Sulpisave-750Ampicillin (as Sodium) + Sulbactam (as Sodium)
500mg/250mg Powder for injection (IV/IM)USP Type II glass vial x 10 mL sealed with butyl rubber stopper and aluminum flip-off cap (Box of 1's)
Rx
REYOUNG PHARMACEUTICAL CO., LTD.China
SAVELINK PHARMA AND TRADING CO.Importer: AGLOBAL CARE, INC.
DRP-12252-02
Jul 4, 2027
SultacillinAmpicillin (as Sodium) + Sulbactam (as Sodium)
1 g/500 mg powder for injection (IM/IV)Clear and colorless glass vial with green flip-off seal with logo (Box of 10's)
Rx
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.China
PharmAsia-Cuvest Incorporated
DR-XY30397
Dec 14, 2029
SultacillinAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg powder for injection (IM/IV)Clear and colorless glass vial with green flip-off seal with logo (Box of 10's)
Rx
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.China
PHARMASIA-CUVEST INCORPORATED
DR-XY30396
Dec 14, 2029
SulvacilAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I Glass Vial x 10’s (Box of 10’s)
Rx
Shin Poong Pharmaceutical Co., Ltd.Republic of Korea
Elin Pharmaceuticals, Inc.Importer: Phil Shin Poong Pharma, Inc.
DRP-5382-02
Jul 10, 2029
SulvacilAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Glass Vial x 10's (Box of 10's)
Rx
Shin Poong Pharmaceutical Co., Ltd.Korea
Elin Pharmaceuticals, Inc.Importer: Phil. Shin Poong Pharma, Inc.
DRP-5442-02
May 31, 2027
Surpitam-1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/500 Powder for Injection (I.M./I.V.)10 mL-capacity USP Type II clear and colorless glass vial with butyl rubber stopper and aluminum seal with blue flip-off cap in a plastic tray (Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Pharma-Surrey International, Inc.
DRP-14263
Aug 4, 2028
Surpitam-750Ampicillin (as sodium) + Sulbactam (as sodium)
500mg/250mg Powder for Injection (I.M./I.V.)10mL - capacity USP Type II clear and colorless glass vial with butyl rubber stopper and aluminum seal with blue flip-off cap in a plastic tray (Box of 10's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Pharma-Surrey International, Inc.
DRP-14262
Aug 4, 2028
SybactamAmpicillin (as Sodium) + Sulbactam (as Sodium)
500 mg / 250 mg Powder for Injection (IV/IM)
Rx
BIORX PHARMA LABS LLP
—
DRP-6930-11
Nov 25, 2026
SynthopenAmpicillin (as sodium) + Sulbactam (as sodium)
1.5 g Powder for Injection (IM/IV)20 mL USP Type I Glass Vial with Grey Butyl Rubber Closure with Leaf Green Aluminum Flip-off seal (Box of 1’s)
Rx
Unichem Laboratories Limited (Unit I)India
Ambica International Corporation
DRP-3649
Dec 18, 2028
SynthopenAmpicillin (as sodium) + Sulbactam (as sodium)
750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Glass Vial with Grey Butyl Rubber Closure with Burgundy Aluminum Flip-off seal (Box of 1’s)
Rx
Unichem Laboratories Limited (Unit I)India
Oro Sinai Pharma & General Merchandise, Inc.Importer: Ambica International Corporation
DRP-3648
Dec 18, 2028
UnacilynAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type III Clear Colorless Glass Vial Sealed with Grey BromoButyl Rubber Stopper and Flip-off Seal x 20 mL (Box of l's)
Rx
Karnataka Antibiotics & Pharma Ltd.India
Jackson Pharmaceuticals Inc.
DR-XY47595
Dec 9, 2026
UnacilynAmpicillin (As Sodium) + Sulbactam (As Sodium)
750 mg Sterile Powder For Injection10cc USP type III glass vials with 20mm grey bromo buytyl rubber stoppers and sealed in blue flip off seals (Box of 1's)
Rx
KARNATAKA ANTIBIOTICS & PHARMA LTD.India
JACKSON PHARMACEUTICALS INC.
DR-XY46453
Nov 14, 2028
UNAMAXAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection(IM/IV)USP Type I Glass Vial x 10’s (Box of 10’s)
Rx
Shin Poong Pharmaceutical Co., Ltd.Republic of Korea
MAXIPHARM CO., LTD.Importer: PHIL SHINPOONG PHARMA, INC.
DRP-5382-01
Jul 10, 2029
Unamax-750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Glass Vial x 10's (Box f 10's)
Rx
Shin Poong Pharmaceutical Co., LtdKorea
Maxipharm Co., Ltd.Importer: Phil. Shin Poong Pharma, Inc.
DRP-5442-01
May 31, 2027
UnasynAmpicillin (as Sodium) + Sulbactam (as Sodium)
1 g/500 mg per vial Powder for Injection (I.M./I/V.)Clear Glass Vial with Grey rubber stopper with Blue flip-off (Box of 1's)
Rx
Haupt Pharma Latina S.r.l.Italy
Importer: Pfizer, Inc.
DRP-1901
Feb 9, 2031
UnathixAmpicillin Sodium + Sulbactam Sodium
500 mg/250 mg Powder For Injection (Im/Iv)USP Type III clear glass vial with white flip-off seal
Rx
—
—
DRP-2607-01
Nov 22, 2028
UnatreneAmpicillin (as sodium) + Sulbactam (as sodium)
1g/500mg Powder for Injection(IM/IV)USP Type I Glass Vial x 10’s (Box of 10’s)
Rx
Shin Poong Pharmaceutical Co., Ltd.Republic of Korea
Aisec Farma CorporationImporter: Phil Shinpoong Pharma, Inc.
DRP-5382-04
Jul 10, 2029
UnatreneAmpicillin (as Sodium) + Sulbactam(as Sodium)
500mg/250mg Powder for Injection (IM/IV)USP Type I Glass Vial x 10’s (Box of 10’s)
Rx
Shin Poong Pharmaceutical Co., Ltd.Republic of Korea
Aisec Farma CorporationImporter: Phil Shinpoong Pharma, Inc.
DRP-5442-05
May 31, 2027
Unazeus 1.5Ampicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (I.V./I.M.)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Flip-off Cap (Box of 10’s)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Ambicare Pharmaceuticals Inc.
DRP-11465
Mar 15, 2032
Unazeus 750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (I. V ./I.M.)USP Type II Tubular Glass Vial with Butyl Rubber Stopper and Flip-off Cap (Box of 10’s)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Ambicare Pharmaceuticals Inc.
DRP-11464
Mar 15, 2032
UnazilAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)USP Type I clear glass vial x 10 mL with grey bromobutyl rubber stopper, aluminum seal, and dark beige flip-off cap (Box of 1 finished product + 5 mL Sterile Water for Injection diluent x 1 ampoule); and (Box of 10's; without diluent)
Rx
Friends Pharma (Pvt.) Ltd.Pakistan
Raquel-Abbas Pharmaceuticals & General Merchandise
DRP-17757
Feb 27, 2032
UnbrandedAmpicillin (as sodium) + Sulbactam (as sodium)
1 g/ 500 mg Powder for Injection (I.M./I.V.)USP Type I clear Glass Vial Box of 1’s
Rx
Unichem Laboratories LimitedIndia
International Pharmaceuticals, Inc.Importer: Ambica International Corporation
DRP-5079-01
Feb 11, 2029
UnsinAmpicillin (as sodium) + Sulbactam (as sodium)
500mg/250mg Powder for Injection (IM/IV)1 USP Type III Glass Vial with secondary box Box of 1's
Rx
2 World LaboratoriesIndia
2 World Traders Subic Inc.
DR-XY39162
Mar 10, 2031
Vactrimed 1.5gAmpicillin (as sodium) + Sulbactam (as sodium)
1g/500mg Powder for Injection (.M./I.V.)Molded glass vial with butyl rubber stopper and aluminum-plastic cap (Box of 1's)
Rx
North China Pharmaceutical Co., Ltd.China
Asianmeds, Inc.Importer: Euro-Care Products Philippines
DRP-12026-01
May 31, 2027
Vactrimed 750Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg / 250 mg Powder for Injection (I.M./I.V.)Molded glass vial with halogenated butyl rubber stopper and aluminum-plastic caps (Box of 1's)
Rx
North China Pharmaceutical Co., Ltd.China
Asianmeds, Inc.Importer: Euro-Care Products Philippines
DRP-12025-01
May 31, 2027
VigosulAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg / 250 mg Powder for Injection (IV/ IM)USP Type II glass vial x 10 mL sealed with butyl rubber stopper and aluminum flip-off cap (Box of 1’s)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Vigorous Health Pharma and Medical Supplies TradingImporter: AGlobal Care, Inc.
DRP-12252-05
Jul 4, 2027
YupitamAmpicillin (as Sodium) + Sulbactam (as Sodium)
500 mg/ 250 mg Powder For Injection (M/IV)10 mL USP Type II Colorless Glass Vial with rubber stopper and blue flip-off seal + 10 mL Type I Clear Colorless Glass Ampoule Sterile Water for Injection as Diluent (Box of 1's)
Rx
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China
AMB HK Enterprises Inc.
DRP-8955
May 17, 2028
ZusillinAmpicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (I.M./I.V.)USP Type I Borosilicate Clear Transparent Glass Vial with Butyl Rubber Stopper Sealed with Aluminum Plastic Cap and Blue Flip-Off x 7 mL (Box of 1’s in 10’s)
Rx
NORTH CHINA PHARMACEUTICAL CO., LTD.China
BELLUS LIFE SOLUTIONS, INC.Importer: AGLOBAL CARE, INC.
DRP-8057-01
Jul 10, 2028
(no brand name)Ampicillin (as sodium) + Sulbactam (as sodium).
1 g/500 mg Powder for Injection (IM/IV)10 mL-capacity USP Type II glass vial with butyl rubber stopper and flip-off cap (Box of 1's)
Rx
Reyoung Pharmaceutical Co., Ltd.China
Khriz Pharma Trading, Inc.
DR-XY49192
Aug 30, 2029
(no brand name)Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)10 mL-capacity USP Type II glass vial with butyl rubber stopper and flip-off cap (Box of 1's)
Rx
Reyoung Pharmaceutical Co., LtdChina
Khriz Pharma Trading, Inc.
DR-XY49191
Aug 30, 2029
(no brand name)Ampicillin (as sodium) + Sulbactam (as sodium)
500 mg/250 mg Powder for Injection (IM/IV)USP Type I Glass Vial x 10's (Box of 10's)
Rx
Shin Poong Pharmaceuticals Co., Ltd.Korea
RiteMed Phils., Inc.Importer: Phil Shinpoong Pharma, Inc.
DRP-5442-03
May 31, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

WARNINGS Hypersensitivity Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on penicillin therapy. These reactions are more apt to occur in individuals with a history of penicillin hypersensitivity and/or hypersensitivity reactions to multiple allergens. There have been reports of individuals with a history of penicillin hypersensitivity who have experienced severe reactions when treated with cephalosporins.

Before therapy with a penicillin, careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, and other allergens. If an allergic reaction occurs, UNASYN should be discontinued and the appropriate therapy instituted. Hepatotoxicity Hepatic dysfunction, including hepatitis and cholestatic jaundice has been associated with the use of UNASYN.

Hepatic toxicity is usually reversible; however, deaths have been reported. Hepatic function should be monitored at regular intervals in patients with hepatic impairment. Severe Cutaneous Adverse Reactions UNASYN may cause severe skin reactions, such as toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS), drug reaction with eosinophilia and systemic symptoms (DRESS), dermatitis exfoliative, erythema multiforme, and Acute generalized exanthematous pustulosis (AGEP).

If patients develop a skin rash they should be monitored closely and UNASYN discontinued if lesions progress (see CONTRAINDICATIONS and ADVERSE REACTIONS sections). Clostridioides difficile -Associated Diarrhea Clostridioides difficile -associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including UNASYN, and may range in severity from mild diarrhea to fatal colitis.

Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile. C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy.

CDAD must be considered in all patients who present with diarrhea following antibacterial drug use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibacterial drug use not directed against C. difficile may need to be discontinued.

Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.

Drug interactions

Drug or classSeverityEffectWhat to do
ProbenecidAdjust or monitorRaises and prolongs ampicillin and sulbactam levels (label).Usually avoid; monitor if used.
AllopurinolMinorMore skin rash with ampicillin-class drugs (label).Usually no action; counsel.
Aminoglycosides (same syringe or bag)MinorInactivated in vitro when mixed (label).Give separately.

Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.

renalcarematters.com, reviewed
Drug interactions (US label) US FDA label

Drug Interactions Probenecid decreases the renal tubular secretion of ampicillin and sulbactam. Concurrent use of probenecid with UNASYN may result in increased and prolonged blood levels of ampicillin and sulbactam. The concurrent administration of allopurinol and ampicillin increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving ampicillin alone.

It is not known whether this potentiation of ampicillin rashes is due to allopurinol or the hyperuricemia present in these patients. There are no data with UNASYN and allopurinol administered concurrently. UNASYN and aminoglycosides should not be reconstituted together due to the in vitro inactivation of aminoglycosides by the ampicillin component of UNASYN.

Adverse reactions

Common

  • Injection-site pain (IM 16%, IV 3%), thrombophlebitis
  • Diarrhea (3%), rash (under 2%)

Serious

  • Anaphylaxis; severe skin reactions
  • Hepatic dysfunction and cholestatic jaundice
  • Clostridioides difficile-associated diarrhea
  • Seizures with very high levels
renalcarematters.com, reviewed
Adverse reactions (US label) US FDA label

ADVERSE REACTIONS Adult Patients UNASYN is generally well tolerated. The following adverse reactions have been reported in clinical trials. Local Adverse Reactions Pain at IM injection site – 16% Pain at IV injection site – 3% Thrombophlebitis – 3% Phlebitis – 1.2% Systemic Adverse Reactions The most frequently reported adverse reactions were diarrhea in 3% of the patients and rash in less than 2% of the patients.

Additional systemic reactions reported in less than 1% of the patients were: itching, nausea, vomiting, candidiasis, fatigue, malaise, headache, chest pain, flatulence, abdominal distension, glossitis, urine retention, dysuria, edema, facial swelling, erythema, chills, tightness in throat, substernal pain, epistaxis and mucosal bleeding. Pediatric Patients Available safety data for pediatric patients treated with UNASYN demonstrate a similar adverse events profile to those observed in adult patients.

Additionally, atypical lymphocytosis has been observed in one pediatric patient receiving UNASYN. Adverse Laboratory Changes Adverse laboratory changes without regard to drug relationship that were reported during clinical trials were: Hepatic: Increased AST (SGOT), ALT (SGPT), alkaline phosphatase, and LDH. Hematologic: Decreased hemoglobin, hematocrit, RBC, WBC, neutrophils, lymphocytes, platelets and increased lymphocytes, monocytes, basophils, eosinophils, and platelets.

Blood Chemistry: Decreased serum albumin and total proteins. Renal: Increased BUN and creatinine. Urinalysis: Presence of RBC's and hyaline casts in urine. Post-marketing Experience In addition to adverse reactions reported from clinical trials, the following have been identified during post-marketing use of ampicillin sodium and sulbactam sodium or other products containing ampicillin.

Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. These events have been chosen for inclusion due to a combination of their seriousness, frequency, or potential causal connection to ampicillin sodium and sulbactam sodium. Infections and Infestations: Clostridioides difficile -associated diarrhea (see WARNINGS section).

Blood and Lymphatic System Disorders: Hemolytic anemia, thrombocytopenic purpura, and agranulocytosis have been reported. These reactions are usually reversible on discontinuation of therapy and are believed to be hypersensitivity phenomena. Some individuals have developed positive direct Coombs Tests during treatment with UNASYN, as with other beta-lactam antibacterials.

Gastrointestinal Disorders: Abdominal pain, cholestatic hepatitis, cholestasis, hyperbilirubinemia, jaundice, abnormal hepatic function, melena, gastritis, stomatitis, dyspepsia, and black "hairy" tongue (see CONTRAINDICATIONS AND WARNINGS sections). General Disorders and Administration Site Conditions: Injection site reaction Immune System Disorders: Serious and fatal hypersensitivity (anaphylactic) reactions (see WARNINGS section), Acute myocardial ischemia with or without myocardial infarction may occur as part of an allergic reaction.

Metabolism and Nutrition Disorders: Hypokalemia Nervous System Disorders: Convulsion and dizziness Renal and Urinary Disorders: Tubulointerstitial nephritis Musculoskeletal and Connective Tissue Disorders: Arthralgia Respiratory, Thoracic and Mediastinal Disorders: Dyspnea Skin and Subcutaneous Tissue Disorders: Toxic epidermal necrolysis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), angioedema, Acute generalized exanthematous pustulosis (AGEP), erythema multiforme, exfoliative dermatitis, urticaria (see CONTRAINDICATIONS and WARNINGS sections), and linear IgA bullous dermatosis.

Monitoring parameters

  • CrCl for dose; seizures with high CSF beta-lactam levels (label overdose section); liver tests (history of cholestatic jaundice is a contraindication); rash; diarrhea (CDAD). Kidney
  • CrCl for dose
  • Liver tests if symptoms
  • Rash, diarrhea
renalcarematters.com, reviewed

Pregnancy considerations

Pregnancy (US label) US FDA label

Pregnancy Reproduction studies have been performed in mice, rats, and rabbits at doses up to ten (10) times the human dose and have revealed no evidence of impaired fertility or harm to the fetus due to UNASYN. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed (see PRECAUTIONS-Drug/Laboratory Test Interactions section).

Breastfeeding considerations

Lactation (US label) US FDA label

Nursing Mothers Low concentrations of ampicillin and sulbactam are excreted in the milk; therefore, caution should be exercised when UNASYN is administered to a nursing woman.

Pharmacokinetics

Key PK parameters

Time to peakIM 1 g/0.5 g: ampicillin 8 to 37 mcg/mL, sulbactam 6 to 24 mcg/mL
Half-lifeAbout 1 hour for each
Half-life in kidney failure (ESKD) kidneyAbout 5 hours at CrCl 15–29 and 9 hours at CrCl 5–14 (label Table 3)
Protein bindingAmpicillin 28%; sulbactam 38%
Renal excretion kidney75% to 85% of each unchanged in urine in 8 hours
Dialyzability kidneyAmpicillin yes; sulbactam probably (label)
renalcarematters.com, reviewed
Half-life and elimination (verbatim, US label)

The mean serum half-life of both drugs is approximately 1 hour in healthy volunteers.

Approximately 75 to 85% of both ampicillin and sulbactam are excreted unchanged in the urine during the first 8 hours after administration of UNASYN to individuals with normal renal function.

Mean half-life values were approximately 1 hour.

Pharmacokinetics (US label) US FDA label

CLINICAL PHARMACOLOGY General Immediately after completion of a 15-minute intravenous infusion of UNASYN, peak serum concentrations of ampicillin and sulbactam are attained. Ampicillin serum levels are similar to those produced by the administration of equivalent amounts of ampicillin alone. Peak ampicillin serum levels ranging from 109 to 150 mcg/mL are attained after administration of 2000 mg of ampicillin plus 1000 mg sulbactam and 40 to 71 mcg/mL after administration of 1000 mg ampicillin plus 500 mg sulbactam.

The corresponding mean peak serum levels for sulbactam range from 48 to 88 mcg/mL and 21 to 40 mcg/mL, respectively. After an intramuscular injection of 1000 mg ampicillin plus 500 mg sulbactam, peak ampicillin serum levels ranging from 8 to 37 mcg/mL and peak sulbactam serum levels ranging from 6 to 24 mcg/mL are attained.

The mean serum half-life of both drugs is approximately 1 hour in healthy volunteers. Approximately 75 to 85% of both ampicillin and sulbactam are excreted unchanged in the urine during the first 8 hours after administration of UNASYN to individuals with normal renal function. Somewhat higher and more prolonged serum levels of ampicillin and sulbactam can be achieved with the concurrent administration of probenecid.

In patients with impaired renal function the elimination kinetics of ampicillin and sulbactam are similarly affected, hence the ratio of one to the other will remain constant whatever the renal function. The dose of UNASYN in such patients should be administered less frequently in accordance with the usual practice for ampicillin (see DOSAGE AND ADMINISTRATION section).

Ampicillin has been found to be approximately 28% reversibly bound to human serum protein and sulbactam approximately 38% reversibly bound. The following average levels of ampicillin and sulbactam were measured in the tissues and fluids listed: TABLE 1 Concentration of UNASYN in Various Body Tissues and Fluids Fluid or Tissue Dose (grams) Ampicillin/Sulbactam Concentration (mcg/mL or mcg/g) Ampicillin/Sulbactam Peritoneal Fluid 0.5/0.5 IV 7/14 Blister Fluid (Cantharides) 0.5/0.5 IV 8/20 Tissue Fluid 1/0.5 IV 8/4 Intestinal Mucosa 0.5/0.5 IV 11/18 Appendix 2/1 IV 3/40 Penetration of both ampicillin and sulbactam into cerebrospinal fluid in the presence of inflamed meninges has been demonstrated after IV administration of UNASYN.

The pharmacokinetics of ampicillin and sulbactam in pediatric patients receiving UNASYN are similar to those observed in adults. Immediately after a 15-minute infusion of 50 to 75 mg UNASYN/kg body weight, peak serum and plasma concentrations of 82 to 446 mcg ampicillin/mL and 44 to 203 mcg sulbactam/mL were obtained. Mean half-life values were approximately 1 hour.

MICROBIOLOGY Mechanism of Action Ampicillin is similar to benzyl penicillin in its bactericidal action against susceptible organisms during the stage of active multiplication. It acts through the inhibition of cell wall mucopeptide biosynthesis. Ampicillin has a broad spectrum of bactericidal activity against many gram-positive and gram-negative aerobic and anaerobic bacteria.

(Ampicillin is, however, degraded by beta-lactamases and therefore the spectrum of activity does not normally include organisms which produce these enzymes). A wide range of beta-lactamases found in microorganisms resistant to penicillins and cephalosporins have been shown in biochemical studies with cell free bacterial systems to be irreversibly inhibited by sulbactam.

Although sulbactam alone possesses little useful antibacterial activity except against the Neisseriaceae, whole organism studies have shown that sulbactam restores ampicillin activity against beta-lactamase producing strains. In particular, sulbactam has good inhibitory activity against the clinically important plasmid mediated beta-lactamases most frequently responsible for transferred drug resistance.

Sulbactam has no effect on the activity of ampicillin against ampicillin-susceptible strains. The presence of sulbactam in the UNASYN formulation effectively extends the antibacterial spectrum of ampicillin to include many bacteria normally resistant to it and to other beta-lactam antibacterials. Thus, UNASYN possesses the properties of a broad-spectrum antibacterial and a beta-lactamase inhibitor.

Antimicrobial Activity While in vitro studies have demonstrated the susceptibility of most strains of the following organisms, clinical efficacy for infections other than those included in the INDICATIONS AND USAGE section has not been documented. Gram-positive Bacteria: Staphylococcus aureus (beta-lactamase and non-beta-lactamase producing) Staphylococcus epidermidis (beta-lactamase and non-beta-lactamase producing) Staphylococcus saprophyticus (beta-lactamase and non-beta-lactamase producing) Enterococcus faecalis Streptococcus pneumoniae Streptococcus pyogenes Streptococcus viridans Gram-negative Bacteria: Hemophilus influenzae (beta-lactamase and non-beta-lactamase producing) Moraxella catarrhalis (beta-lactamase and non-beta-lactamase producing) Escherichia coli (beta-lactamase and non-beta-lactamase producing) Klebsiella species (all known strains are beta-lactamase producing) Proteus mirabilis (beta-lactamase and non-beta-lactamase producing) Proteus vulgaris Providencia rettgeri Providencia stuartii Morganella morganii Neisseria gonorrhoeae (beta-lactamase and non-beta-lactamase producing) Anaerobes: Clostridium species These are not beta-lactamase producing strains and, therefore, are susceptible to ampicillin alone.

Peptococcus species Peptostreptococcus species Bacteroides species, including B. fragilis Susceptibility Testing For specific information regarding susceptibility test interpretive criteria and associated test methods and quality control standards recognized by FDA for this drug, please see: https://www.fda.gov/STIC.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Ampicillin + Sulbactam 1.5 g Vial₱28.89–₱300.00Reference ₱58.17per vialDPRI procurement range
Ampicillin + Sulbactam 500mg + 250 mg Vial₱17.88–₱249.90Reference ₱21.14per vialDPRI procurement range

Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Ampicillin + Sulbactam
PNF listingInj.: 500 mg ampicillin + 250 mg sulbactam (IM, IV) (as sodium salt) per vial
PNF listingInj.: 1000 mg ampicillin + 500 mg sulbactam (IM, IV) (as sodium salt) per vial
PNF listingInj.: 2000 mg ampicillin + 1000 mg sulbactam (IM, IV) (as sodium salt) per vial
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. UNASYN · Roerig [US FDA-approved label, version 46, July 10, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=155c7ec0-5862-404f-b1d0-f278f8a8bbda
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
  5. Roerig. (2026). UNASYN (ampicillin sodium and sulbactam sodium) for injection [Prescribing information; US FDA-approved label, NDA050608, set ID 155c7ec0-5862-404f-b1d0-f278f8a8bbda, version effective July 10, 2026]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=155c7ec0-5862-404f-b1d0-f278f8a8bbda
  6. Li, L., Li, X., Xia, Y., Chu, Y., Zhong, H., Li, J., Liang, P., Bu, Y., Zhao, R., Liao, Y., Yang, P., Lu, X., & Jiang, S. (2020). Recommendation of antimicrobial dosing optimization during continuous renal replacement therapy. Frontiers in Pharmacology, 11, Article 786. https://doi.org/10.3389/fphar.2020.00786
  7. Li, P. K.-T., Chow, K. M., Cho, Y., Fan, S., Figueiredo, A. E., Harris, T., Kanjanabuch, T., Kim, Y.-L., Madero, M., Malyszko, J., Mehrotra, R., Okpechi, I. G., Perl, J., Piraino, B., Runnegar, N., Teitelbaum, I., Wong, J. K.-W., Yu, X., & Johnson, D. W. (2022). ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Peritoneal Dialysis International, 42(2), 110–153. https://doi.org/10.1177/08968608221080586

renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .